Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2000
11/01/2000CN1271583A Chinese patent medicine for treating cancer metastasis
11/01/2000CN1271582A Application of Yanglazi in medicines, cosmetics and health-care products
11/01/2000CN1271533A Health-care pearl-pollen food and preparing process thereof
11/01/2000CN1058050C Beer containing pearl and producing method thereof
11/01/2000CN1057935C Chinese medicinal power preparation for treating hepatocirrhosis
11/01/2000CN1057932C Traditional Chinese medicine composition for external use of curing rheumatic arthritis
11/01/2000CN1057930C Chinese medicine for treating deep phlebothrombosis
11/01/2000CN1057928C Medicine for ulcer and its preparation
11/01/2000CN1057927C Health products able to suppress tumour cell
11/01/2000CN1057923C Tonic medicine
11/01/2000CN1057920C Hyperthyroidism plaster and its preparing method
11/01/2000CN1057919C Medicinal preparation for treatment of tumour
11/01/2000CN1057914C Cancer treating pill and its preparing process
11/01/2000CN1057913C Yinchan emulsion
11/01/2000CN1057911C Chinese medicine for treating cardiovascular diseases and its preparing method
11/01/2000CN1057910C Method for preparing preparation made from marrow, brain, liver and blood tortoise and/or turtle
11/01/2000CN1057909C Method for preparation of drained bear bile freeze-dried powder injection
10/2000
10/31/2000US6140472 Use of chimeric vaccinia virus complement control proteins to inhibit complement
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140365 Preparation of microorganisms comprising omega-3-fatty acid for use as a prophylactic or therapeutic agent against parasitic diseases of animals
10/31/2000US6140122 Kits containing compositions which can be used as internal controls in order to control the different stages of the process, particularly to control the contents of monocytes and other constituents of the starting composition
10/31/2000US6140121 Contacting sample containing sperm with solution comprising hexuronic acid monomer or with solution comprising polymer comprising hexuronic acid and arabinose or galactose to form a mixture, separating sperm
10/31/2000US6140116 Adjusted swine neuronal cells for the treatment of humans with stroke, brain trauma, amyotrophic lateral sclerosis, multiple sclerosis, huntington's and alzheimer's disease
10/31/2000US6140114 Defective viral vaccine particles obtained in vivo or ex vivo
10/31/2000US6140112 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases
10/31/2000US6140111 Nucleotide sequences utilized for the treatment of genetic disorders in human and animal somatic cells
10/31/2000US6140089 Jacket confined viable aggregations; for maintaining, propagating, proliferating, and differentiating viable cells trapped between the chitin polysaccharide matrix
10/31/2000US6140039 Comprising fibroblasts and collagen naturally secreted by the fibroblasts attached to and substantially enveloping a three-dimensional filamentous framework composed of a biocompatible, non-living material having interstitial spaces
10/31/2000US6139878 Method for preparing a diafiltered stabilized blood product
10/31/2000US6139844 Method for treating or eliminating a parasitic disease
10/31/2000US6139840 Administering a therapeutic compositions to protect a host animal from flea infestation
10/31/2000US6139836 Lysed and partially lysed red blood cells are concentrated prior to introduction of biologically active agent; resultant carrier red blood cells are stable for extended period of time and can be used for systemic or targeted delivery of drugs
10/31/2000US6139835 Homologous recombination for allogeneic donor cells
10/31/2000US6139834 Capable of killing human tumor cells in vivo; exhibits hypersensitivity to anti-viral agents
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/27/2000CA2307104A1 Human myoblast cell lines and their uses
10/26/2000WO2000063406A2 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules
10/26/2000WO2000063396A1 Method for enhancing myoblast migration and invasion in the context of gene therapy
10/26/2000WO2000063385A2 Nucleic acid immunization
10/26/2000WO2000063378A2 Zalpha13: a human secreted protein
10/26/2000WO2000063368A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000WO2000063364A2 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000WO2000063348A2 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
10/26/2000WO2000063242A1 Chimeric lyssavirus nucleic acids and polypeptides
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000062862A1 Method of prophylaxis and treatment of diabetes
10/26/2000WO2000062833A1 Cellular matrix system and use thereof
10/26/2000WO2000062818A1 Differentiation of monocytes into functional dendritic cells
10/26/2000WO2000062794A1 A non-immunosuppressive process for inducing acceptance of incompatible transplants
10/26/2000WO2000062788A2 Treatment of hypersensitivity reaction disorders
10/26/2000WO2000062779A1 Combination of glucosylceramide synthesis inhibitors and glycolipid degrading enzyme in therapy
10/26/2000WO2000062735A2 Treatment of neoplasms with viruses
10/26/2000WO2000062605A1 eNOS MUTATIONS USEFUL FOR GENE THERAPY AND THERAPEUTIC SCREENING
10/26/2000WO2000039275A3 Multiple shear stress responsive elements (ssre) and methods of use thereof
10/26/2000WO2000038698A3 Substances from porcine tissue
10/26/2000WO2000036089A3 Methods of immunosuppression
10/26/2000WO2000035481A3 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
10/26/2000WO2000034444A3 Method and composition for preserving viruses
10/26/2000WO2000032751A3 Mammalian non-neuronal cells that are modified to store and release a neurotransmitter
10/26/2000WO2000026385A9 Nucleic acid constructs for genetic immunization
10/26/2000DE19918327A1 Generating donor tolerance in humans, useful for inducing compatibility with xenotransplants, comprises injection of fetus or embryo with donor stem cells
10/26/2000DE19917532A1 Carrier-bound keratinocyte stem or precursor cells, useful for cosmetic or therapeutic regeneration of the epidermis
10/26/2000CA2370646A1 Nucleic acid immunization
10/26/2000CA2370628A1 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000CA2370453A1 Treatment of hypersensitivity reaction disorders
10/26/2000CA2370142A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2369764A1 Enos mutations useful for gene therapy and therapeutic screening
10/26/2000CA2368029A1 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
10/25/2000EP1046711A2 Recombinant adeno-associated virus
10/25/2000EP1046400A1 Methods and compositions for treating human cells
10/25/2000EP1046397A2 Novel bioactivating substance
10/25/2000EP1045920A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy
10/25/2000EP1045919A1 Novel promoter elements for persistent gene expression
10/25/2000EP1045898A2 Compositions and methods for regulated secretion from neuroendocrine cell lines
10/25/2000EP1045862A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation
10/25/2000EP1045704A1 Methods for quenching pathogen inactivators in biological materials
10/25/2000EP1045637A1 Decorated red blood cells
10/25/2000EP1045635A1 Cloning using donor nuclei from differentiated fetal and adult cells
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/25/2000EP0649603B1 Antioxidant food, antioxidant preparation and antioxidization method
10/25/2000EP0627911B1 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
10/25/2000CN1271391A Methods and compositions for therapies using genges encoding secreted proteins such as interferon-beta
10/25/2000CN1270834A Wound healing ointment
10/25/2000CN1270833A Bone fracture setting medicine powder
10/25/2000CN1270826A Chinese medicine preparation for pulmonary tuberculosis and its preparation
10/25/2000CN1270825A Chinese medicine for treading hepatitis A and B and its recipe
10/25/2000CN1270820A Tonic compound deer fetus ointment and its preparation
10/25/2000CN1270819A Bone and muscle bolus
10/25/2000CN1270815A Medicated wine capable of treating several disease
10/25/2000CN1270814A Cough and asthma relieving and phlegm eliminating capsule and its preparation
10/25/2000CN1270813A Diabetes treating medicine
10/25/2000CN1270812A Burn and scald treating medicine and its preparation
10/25/2000CN1270811A Chinese medicine for treating arthralgia and its preparation
10/25/2000CN1057795C Method for producing health care wine by using live scorpions
10/25/2000CN1057702C Drug composition for curing mastosis and its preparing method
10/25/2000CN1057698C Medicine for curing bone fracture
10/25/2000CN1057697C Powder for curing ulcerative colitis and proctitis ulcerosa and its preparing method
10/25/2000CN1057696C Chinese drug composition for curing gastritis
10/25/2000CN1057694C Plaster for treating hyperosteogeny and its prepn. method
1 ... 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 ... 1259